Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Assess the Cognitive Effects of a Citicoline Supplement (Cognizin®) on Attention in Healthy Men and Women

NCT04967157 is registered in ClinicalTrials.gov with Kirin Holdings Company, Limited as lead sponsor.

NCT NCT04967157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04967157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Assess the Cognitive Effects of a Citicoline Supplement (Cognizin®) on Attention in Healthy Men and Women
Lead sponsor
Kirin Holdings Company, Limited
Phase
Not applicable
Overall status
Completed
Start date
September 8, 2021
Completion date
August 31, 2022
Enrollment
148 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy